Open Access Policy

The European Journal of Therapeutics is deeply committed to the principles of open access, ensuring that all scholarly content published within its pages is freely and universally accessible to readers without any subscription fees, paywalls, or other access barriers.

Readers can access the full content of every article published in the European Journal of Therapeutics directly on its official website, https://www.eurjther.com/archive, completely free of charge and without any membership requirements.

European Journal of Therapeutics implements an "Early View" publication model. Under this policy, manuscripts that have completed the peer review process, received editorial acceptance, and undergone final typesetting are published online with a Digital Object Identifier (DOI) before being assigned to a specific volume and issue. For details, please refer to the Early View Publication Policy page.

All articles published in the European Journal of Therapeutics are licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0). Under the provisions of this license, both third parties and authors are granted the freedom to copy, distribute, transmit, and adapt the material, provided the article is properly cited and the use is for non-commercial purposes. This includes the right to remix, transform, and build upon the material.

Authors are required to sign a Copyright Agreement and Acknowledgement of Authorship Form, which explicitly states that authors maintain complete ownership of all patent and other proprietary rights, including copyright, on their published articles without restriction. For details, please refer to the Copyright and Licensing page.

To facilitate immediate and unrestricted dissemination of knowledge, all articles are made available on the journal’s website without any embargo periods. The European Journal of Therapeutics actively encourages authors to self-archive their published work in institutional repositories, personal websites, or other suitable platforms, further enhancing the accessibility and broad dissemination of their research.

The publishing policies of the European Journal of Therapeutics are framed within the standards of transparency and best practices for scholarly publishing, as established by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME).

¹ COPE, DOAJ, OASPA, WAME. Principles of Transparency and Best Practice in Scholarly Publishing. Available at: https://doi.org/10.24318/cope.2019.1.12

 

Repository Policy

The European Journal of Therapeutics actively encourages authors to self-archive the final published version of their articles (Preprint, Accepted Manuscript, Published article) in institutional repositories, personal websites, or other suitable platforms, further enhancing the accessibility of their research. When sharing or redistributing their work, authors and readers are required to provide accurate citations, including the DOI link to the publisher's definitive version. This practice upholds proper credit and academic integrity. Self-archiving is encouraged across various platforms, including institutional repositories, social media, and educational networking sites, always with a clear reference to the publisher's final version. All articles published in the European Journal of Therapeutics are licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0). Under the provisions of this license, both third parties and authors are granted the freedom to copy, distribute, transmit, and adapt the material, provided the article is properly cited and the use is for non-commercial purposes. This includes the right to remix, transform, and build upon the material. By implementing these comprehensive practices, the European Journal of Therapeutics ensures that research remains readily accessible, discoverable, and securely preserved for future generations of scholars and practitioners.

 

Archiving Policy

The European Journal of Therapeutics is dedicated to ensuring the long-term preservation and accessibility of its published scholarly content. We maintain the principle of immediate open access for our archived content, with no embargo periods and no requirement for users to register to read it.

The European Journal of Therapeutics utilizes the Open Journal Systems (OJS) platform, which naturally supports robust data management and metadata standards critical for effective archiving. Our archiving policy aims for all articles to remain permanently accessible for future researchers and the broader public, even under unforeseen circumstances. To achieve this, the European Journal of Therapeutics employs the PKP Preservation Network (PN), LOCKSS, CLOCKSS, and GAÜN DSpace (Gaziantep University) archiving systems. Key metadata associated with the journal and each article is meticulously preserved.

The content of this journal is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0). Under the provisions of this license, both third parties and authors are granted the freedom to copy, distribute, transmit, and adapt the material, provided the article is properly cited and the use is for non-commercial purposes. This includes the right to remix, transform, and build upon the material.

 

Ownership and Management

The European Journal of Therapeutics is the official publication organ of Gaziantep University. The Rector, acting as the proprietor on behalf of the University, is responsible for the appointment of the Editor-in-Chief. The journal's publication and evaluation processes are managed by the Editorial Board, which the Editor-in-Chief appoints.

The Editor-in-Chief of the journal is the authority and the final decision maker in the evaluation and publication processes.

The Gaziantep University Scientific Research Projects Unit covers all expenses of the journal. An independent publisher provides publishing services. The Editor-in-Chief selects this publisher, which undertakes tasks such as managing the publication secretariat, preparing articles for publication, assigning DOIs, and managing the journal's website and online peer review system.

 

Last Revised on August 2025